Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atasi Poddar

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Therapeutic Innovation & Regulatory Science|November 5, 2023
Decisions on Non-oncology Breakthrough Therapy Designation Requests in 2017-2019Atasi Poddar, Miranda Raggio, John Concato
Eukaryotic Cell|May 10, 2005
Two complexes of spindle checkpoint proteins containing Cdc20 and Mad2 assemble during mitosis independently of the kinetochore in Saccharomyces cerevisiaeAtasi Poddar, P Todd Stukenberg, Daniel J Burke
Cell Cycle (Georgetown, Tex.)|January 9, 2004
Differential kinetochore requirements for establishment and maintenance of the spindle checkpoint are dependent on the mechanism of checkpoint activation in Saccharomyces cerevisiaeAtasi Poddar, Jewel A Daniel, John R Daum, et al.
Journal of Virology|November 14, 2008
The human papillomavirus type 8 E2 tethering protein targets the ribosomal DNA loci of host mitotic chromosomesAtasi Poddar, Shawna C Reed, Maria G McPhillips, et al.
NEJM AI|December 12, 2025
Mitigating Limited Data Challenges to Improve Artificial Intelligence Integration in Rare Disease Drug DevelopmentAtasi Poddar, Gabriel K Innes, Qi Liu, et al.
NEJM AI|December 12, 2025
Leveraging Artificial Intelligence in Drug and Biological Product Development: An FDA and Clinical Trial Transformation Initiative Workshop ReportAtasi Poddar, Marsha Samson, Gabriel K Innes, et al.
Journal of Clinical Pharmacology|December 15, 2023
Demographic Diversity of Clinical Trials for Therapeutic Drug Products: A Systematic Review of Recently Published Articles, 2017-2022Wambui Chege, Atasi Poddar, Marsha E Samson, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Therapeutic Innovation & Regulatory Science|November 5, 2023
Decisions on Non-oncology Breakthrough Therapy Designation Requests in 2017-2019Atasi Poddar, Miranda Raggio, John Concato
Eukaryotic Cell|May 10, 2005
Two complexes of spindle checkpoint proteins containing Cdc20 and Mad2 assemble during mitosis independently of the kinetochore in Saccharomyces cerevisiaeAtasi Poddar, P Todd Stukenberg, Daniel J Burke
Cell Cycle (Georgetown, Tex.)|January 9, 2004
Differential kinetochore requirements for establishment and maintenance of the spindle checkpoint are dependent on the mechanism of checkpoint activation in Saccharomyces cerevisiaeAtasi Poddar, Jewel A Daniel, John R Daum, et al.
Journal of Virology|November 14, 2008
The human papillomavirus type 8 E2 tethering protein targets the ribosomal DNA loci of host mitotic chromosomesAtasi Poddar, Shawna C Reed, Maria G McPhillips, et al.
NEJM AI|December 12, 2025
Mitigating Limited Data Challenges to Improve Artificial Intelligence Integration in Rare Disease Drug DevelopmentAtasi Poddar, Gabriel K Innes, Qi Liu, et al.
NEJM AI|December 12, 2025
Leveraging Artificial Intelligence in Drug and Biological Product Development: An FDA and Clinical Trial Transformation Initiative Workshop ReportAtasi Poddar, Marsha Samson, Gabriel K Innes, et al.
Journal of Clinical Pharmacology|December 15, 2023
Demographic Diversity of Clinical Trials for Therapeutic Drug Products: A Systematic Review of Recently Published Articles, 2017-2022Wambui Chege, Atasi Poddar, Marsha E Samson, et al.
Pageof 1